BATS BZX Real-Time Price
As of 9:55am ET
| -2.72 / -0.92%|
The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 362.00, with a high estimate of 480.00 and a low estimate of 290.00. The median estimate represents a +23.99% increase from the last price of 291.96.
The current consensus among 28 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.